This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of insulin aspart 100 unit/mL, a critical pharmaceutical product, with a ceiling value of $5,223.82. The contract has an ultimate completion date of August 12, 2024 and is a firm fixed-price delivery order. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of insulin aspart medication in 10 mL vials. The $9,896.55 delivery order contract, placed by the Defense Logistics Agency (DLA), has a firm fixed price and an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of 4565029580 - Insulin Aspart 100 Unit/mL Vial 10mL to the U.S. Defense Department's Medical Supply Chain agency. The $1,162.30 firm fixed-price delivery order contract has a completion date of July 1, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, leverages its extensive supply chain to fulfill government contracts for a wide range of...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,943.52 Firm Fixed Price Delivery Order is for the supply of Insulin Aspart 100 Unit/mL vials. The contract has an ultimate completion date of April 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/mL, a diabetes medication, with a ceiling value of $2,217.34 and a completion date of July 3, 2025. The contract is a firm fixed-price delivery order, meaning Amerisourcebergen will provide the medication at a predetermined price. This contract is...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply Insulin Aspart 100 Unit/ML Pen 3ML to the U.S. Department of Defense (DoD) and its agencies. The $2,379.74 Firm Fixed Price Delivery Order contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,738.08 firm fixed-price contract is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML, a medical supply product. The contract has an ultimate completion date of April 21, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,195.52, is for the provision of Insulin Aspart 100 unit/mL pens with a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery...
This federal contract award, valued at $7,553.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of insulin aspart 100 unit/mL vials, with a period of performance extending through April 2025. The contract is not designated as a set-aside and is therefore open to competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to supply 4565723173 - INSULIN ASPART 100 UNIT/ML VL 10ML. The contract has a ceiling value of $2,545.20 and an ultimate completion date of September 10, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of...